Calidi Biotherapeutics CEO Allan Camaisa sells $16,200 in stock By Investing.com

SAN DIEGO—Allan Camaisa, CEO and Chairman of the Board at Calidi Biotherapeutics, Inc. (NASDAQ:CLDI), recently sold 10,000 shares of the company’s common stock. The shares were sold at a price of $1.62 each, amounting to a total transaction value of $16,200. Following this sale, Camaisa holds 66,712 shares directly. The transaction comes as CLDI shares … Read more

Ukraine's Zelensky meets with key European leaders as Trump looms

Ukrainian President Volodymyr Zelensky held talks with NATO Secretary General Mark Rutte and other European leaders on Wednesday, aiming to get immediate help to bolster Kyiv’s war effort and discuss longer-term security guarantees. The talks took place with Ukraine on the defensive on the battlefield and uncertainty hanging over future US support, as President-elect Donald Trump pushes for a quick end to … Read more